Global Calcitonin Gene Related Peptide Type 1 Receptor Market Professional Survey Report 2019
Table of Contents
Executive Summary
1 Industry Overview of Calcitonin Gene Related Peptide Type 1 Receptor
- 1.1 Definition of Calcitonin Gene Related Peptide Type 1 Receptor
- 1.2 Calcitonin Gene Related Peptide Type 1 Receptor Segment by Type
- 1.2.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 AFAP-3
- 1.2.3 AGN-241689
- 1.2.4 CGRP
- 1.2.5 Erenumab
- 1.2.6 Others
- 1.3 Calcitonin Gene Related Peptide Type 1 Receptor Segment by Applications
- 1.3.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Consumption Comparison by Applications (2014-2025)
- 1.3.2 Cardiovascular
- 1.3.3 Metabolic Disorders
- 1.3.4 Dental Pain
- 1.3.5 Others
- 1.4 Global Calcitonin Gene Related Peptide Type 1 Receptor Overall Market
- 1.4.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue (2014-2025)
- 1.4.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Production (2014-2025)
- 1.4.3 North America Calcitonin Gene Related Peptide Type 1 Receptor Status and Prospect (2014-2025)
- 1.4.4 Europe Calcitonin Gene Related Peptide Type 1 Receptor Status and Prospect (2014-2025)
- 1.4.5 China Calcitonin Gene Related Peptide Type 1 Receptor Status and Prospect (2014-2025)
- 1.4.6 Japan Calcitonin Gene Related Peptide Type 1 Receptor Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Calcitonin Gene Related Peptide Type 1 Receptor Status and Prospect (2014-2025)
- 1.4.8 India Calcitonin Gene Related Peptide Type 1 Receptor Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Calcitonin Gene Related Peptide Type 1 Receptor
- 2.3 Manufacturing Process Analysis of Calcitonin Gene Related Peptide Type 1 Receptor
- 2.4 Industry Chain Structure of Calcitonin Gene Related Peptide Type 1 Receptor
3 Development and Manufacturing Plants Analysis of Calcitonin Gene Related Peptide Type 1 Receptor
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Calcitonin Gene Related Peptide Type 1 Receptor
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Calcitonin Gene Related Peptide Type 1 Receptor Production and Capacity Analysis
- 4.2 Calcitonin Gene Related Peptide Type 1 Receptor Revenue Analysis
- 4.3 Calcitonin Gene Related Peptide Type 1 Receptor Price Analysis
- 4.4 Market Concentration Degree
5 Calcitonin Gene Related Peptide Type 1 Receptor Regional Market Analysis
- 5.1 Calcitonin Gene Related Peptide Type 1 Receptor Production by Regions
- 5.1.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Production by Regions
- 5.1.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Regions
- 5.2 Calcitonin Gene Related Peptide Type 1 Receptor Consumption by Regions
- 5.3 North America Calcitonin Gene Related Peptide Type 1 Receptor Market Analysis
- 5.3.1 North America Calcitonin Gene Related Peptide Type 1 Receptor Production
- 5.3.2 North America Calcitonin Gene Related Peptide Type 1 Receptor Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Calcitonin Gene Related Peptide Type 1 Receptor Import and Export
- 5.4 Europe Calcitonin Gene Related Peptide Type 1 Receptor Market Analysis
- 5.4.1 Europe Calcitonin Gene Related Peptide Type 1 Receptor Production
- 5.4.2 Europe Calcitonin Gene Related Peptide Type 1 Receptor Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Calcitonin Gene Related Peptide Type 1 Receptor Import and Export
- 5.5 China Calcitonin Gene Related Peptide Type 1 Receptor Market Analysis
- 5.5.1 China Calcitonin Gene Related Peptide Type 1 Receptor Production
- 5.5.2 China Calcitonin Gene Related Peptide Type 1 Receptor Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Calcitonin Gene Related Peptide Type 1 Receptor Import and Export
- 5.6 Japan Calcitonin Gene Related Peptide Type 1 Receptor Market Analysis
- 5.6.1 Japan Calcitonin Gene Related Peptide Type 1 Receptor Production
- 5.6.2 Japan Calcitonin Gene Related Peptide Type 1 Receptor Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Calcitonin Gene Related Peptide Type 1 Receptor Import and Export
- 5.7 Southeast Asia Calcitonin Gene Related Peptide Type 1 Receptor Market Analysis
- 5.7.1 Southeast Asia Calcitonin Gene Related Peptide Type 1 Receptor Production
- 5.7.2 Southeast Asia Calcitonin Gene Related Peptide Type 1 Receptor Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Calcitonin Gene Related Peptide Type 1 Receptor Import and Export
- 5.8 India Calcitonin Gene Related Peptide Type 1 Receptor Market Analysis
- 5.8.1 India Calcitonin Gene Related Peptide Type 1 Receptor Production
- 5.8.2 India Calcitonin Gene Related Peptide Type 1 Receptor Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Calcitonin Gene Related Peptide Type 1 Receptor Import and Export
6 Calcitonin Gene Related Peptide Type 1 Receptor Segment Market Analysis (by Type)
- 6.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Production by Type
- 6.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Type
- 6.3 Calcitonin Gene Related Peptide Type 1 Receptor Price by Type
7 Calcitonin Gene Related Peptide Type 1 Receptor Segment Market Analysis (by Application)
- 7.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Consumption by Application
- 7.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Consumption Market Share by Application (2014-2019)
8 Calcitonin Gene Related Peptide Type 1 Receptor Major Manufacturers Analysis
- 8.1 Allergan Plc
- 8.1.1 Allergan Plc Calcitonin Gene Related Peptide Type 1 Receptor Production Sites and Area Served
- 8.1.2 Allergan Plc Product Introduction, Application and Specification
- 8.1.3 Allergan Plc Calcitonin Gene Related Peptide Type 1 Receptor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Amgen Inc
- 8.2.1 Amgen Inc Calcitonin Gene Related Peptide Type 1 Receptor Production Sites and Area Served
- 8.2.2 Amgen Inc Product Introduction, Application and Specification
- 8.2.3 Amgen Inc Calcitonin Gene Related Peptide Type 1 Receptor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Biohaven Pharmaceutical Holding Company Ltd
- 8.3.1 Biohaven Pharmaceutical Holding Company Ltd Calcitonin Gene Related Peptide Type 1 Receptor Production Sites and Area Served
- 8.3.2 Biohaven Pharmaceutical Holding Company Ltd Product Introduction, Application and Specification
- 8.3.3 Biohaven Pharmaceutical Holding Company Ltd Calcitonin Gene Related Peptide Type 1 Receptor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Eli Lilly and Company
- 8.4.1 Eli Lilly and Company Calcitonin Gene Related Peptide Type 1 Receptor Production Sites and Area Served
- 8.4.2 Eli Lilly and Company Product Introduction, Application and Specification
- 8.4.3 Eli Lilly and Company Calcitonin Gene Related Peptide Type 1 Receptor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Fortress Biotech Inc
- 8.5.1 Fortress Biotech Inc Calcitonin Gene Related Peptide Type 1 Receptor Production Sites and Area Served
- 8.5.2 Fortress Biotech Inc Product Introduction, Application and Specification
- 8.5.3 Fortress Biotech Inc Calcitonin Gene Related Peptide Type 1 Receptor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Merck & Co Inc
- 8.6.1 Merck & Co Inc Calcitonin Gene Related Peptide Type 1 Receptor Production Sites and Area Served
- 8.6.2 Merck & Co Inc Product Introduction, Application and Specification
- 8.6.3 Merck & Co Inc Calcitonin Gene Related Peptide Type 1 Receptor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Teva Pharmaceutical Industries Ltd
- 8.7.1 Teva Pharmaceutical Industries Ltd Calcitonin Gene Related Peptide Type 1 Receptor Production Sites and Area Served
- 8.7.2 Teva Pharmaceutical Industries Ltd Product Introduction, Application and Specification
- 8.7.3 Teva Pharmaceutical Industries Ltd Calcitonin Gene Related Peptide Type 1 Receptor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Vertex Pharmaceuticals Inc
- 8.8.1 Vertex Pharmaceuticals Inc Calcitonin Gene Related Peptide Type 1 Receptor Production Sites and Area Served
- 8.8.2 Vertex Pharmaceuticals Inc Product Introduction, Application and Specification
- 8.8.3 Vertex Pharmaceuticals Inc Calcitonin Gene Related Peptide Type 1 Receptor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
9 Development Trend of Analysis of Calcitonin Gene Related Peptide Type 1 Receptor Market
- 9.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Market Trend Analysis
- 9.1.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Calcitonin Gene Related Peptide Type 1 Receptor Regional Market Trend
- 9.2.1 North America Calcitonin Gene Related Peptide Type 1 Receptor Forecast 2019-2025
- 9.2.2 Europe Calcitonin Gene Related Peptide Type 1 Receptor Forecast 2019-2025
- 9.2.3 China Calcitonin Gene Related Peptide Type 1 Receptor Forecast 2019-2025
- 9.2.4 Japan Calcitonin Gene Related Peptide Type 1 Receptor Forecast 2019-2025
- 9.2.5 Southeast Asia Calcitonin Gene Related Peptide Type 1 Receptor Forecast 2019-2025
- 9.2.6 India Calcitonin Gene Related Peptide Type 1 Receptor Forecast 2019-2025
- 9.3 Calcitonin Gene Related Peptide Type 1 Receptor Market Trend (Product Type)
- 9.4 Calcitonin Gene Related Peptide Type 1 Receptor Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Calcitonin Gene Related Peptide Type 1 Receptor Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
The global Calcitonin Gene Related Peptide Type 1 Receptor market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Calcitonin Gene Related Peptide Type 1 Receptor volume and value at global level, regional level and company level. From a global perspective, this report represents overall Calcitonin Gene Related Peptide Type 1 Receptor market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Calcitonin Gene Related Peptide Type 1 Receptor in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Calcitonin Gene Related Peptide Type 1 Receptor manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Allergan Plc
Amgen Inc
Biohaven Pharmaceutical Holding Company Ltd
Eli Lilly and Company
Fortress Biotech Inc
Merck & Co Inc
Teva Pharmaceutical Industries Ltd
Vertex Pharmaceuticals Inc
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
AFAP-3
AGN-241689
CGRP
Erenumab
Others
Segment by Application
Cardiovascular
Metabolic Disorders
Dental Pain
Others